Zymeworks (ZYME) EBIT Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) EBIT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -1,651.00 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 29,091.00 |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - | -91,757.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91,757.00 |
| Mar 31, 2026 | -186,225.00 |
| Dec 31, 2025 | -168,395.00 |
| Sep 30, 2025 | 13,371.00 |
| Jun 30, 2025 | 22,148.00 |
| Mar 31, 2025 | 28,241.00 |
| Dec 31, 2024 | 6,678.00 |
| Sep 30, 2024 | -1,242.00 |
| Jun 30, 2024 | 54,997.00 |
| Mar 31, 2024 | -30,021.00 |
| Dec 31, 2023 | -23,665.00 |
| Sep 30, 2023 | 171,266.00 |
| Jun 30, 2023 | 43,670.00 |
| Mar 31, 2023 | 371,695.00 |
| Dec 31, 2022 | 60,889.00 |
| Sep 30, 2022 | -52,690.00 |